173 related articles for article (PubMed ID: 31639796)
41. Elderly Patients with Metastatic Neuroendocrine Tumors Are Undertreated and Have Shorter Survival: The LyREMeNET Study.
Lemelin A; Maucort-Boulch D; Castel-Kremer E; Forestier J; Hervieu V; Lorcet M; Boutitie F; Theillaumas A; Robinson P; Duclos A; Lombard-Bohas C; Walter T
Neuroendocrinology; 2020; 110(7-8):653-661. PubMed ID: 31586998
[TBL] [Abstract][Full Text] [Related]
42. Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3.
Merola E; Falconi M; Rinke A; Staettner S; Krendl F; Partelli S; Andreasi V; Gress TM; Pascher A; Arsenic R; Doglioni C; Kaemmerer D; Wiedenmann B; Pavel ME
Am J Surg; 2020 Aug; 220(2):284-289. PubMed ID: 32209239
[TBL] [Abstract][Full Text] [Related]
43. Patterns of Recurrence after Resection for Pancreatic Neuroendocrine Tumors: Who, When, and Where?
Marchegiani G; Landoni L; Andrianello S; Masini G; Cingarlini S; D'Onofrio M; De Robertis R; Davì M; Capelli P; Manfrin E; Amodio A; Paiella S; Malleo G; Damoli I; Miotto M; Bianchi B; Nessi C; Vivani E; Scarpa A; Salvia R; Bassi C
Neuroendocrinology; 2019; 108(3):161-171. PubMed ID: 30481765
[TBL] [Abstract][Full Text] [Related]
44. Bisphosphonates for breast cancer.
Pavlakis N; Stockler M
Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
[TBL] [Abstract][Full Text] [Related]
45. Pattern and risk factors for distant metastases in gastrointestinal neuroendocrine neoplasms: a population-based study.
Cai W; Tan Y; Ge W; Ding K; Hu H
Cancer Med; 2018 Jun; 7(6):2699-2709. PubMed ID: 29733523
[TBL] [Abstract][Full Text] [Related]
46. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.
Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A
Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181
[TBL] [Abstract][Full Text] [Related]
47. Benefit of Gene Expression Profiling in Gastrointestinal Neuroendocrine Tumors of Unknown Primary Origin.
Saller JJ; Haider M; Al-Diffalha S; Coppola D
Anticancer Res; 2022 Mar; 42(3):1381-1396. PubMed ID: 35220231
[TBL] [Abstract][Full Text] [Related]
48. A Real-World, Population-Based Study for the Incidence and Outcomes of Neuroendocrine Neoplasms of Unknown Primary.
Abdel-Rahman O
Neuroendocrinology; 2021; 111(9):876-882. PubMed ID: 32980845
[TBL] [Abstract][Full Text] [Related]
49. Predictive Value of 99MTC-hynic-toc Scintigraphy in Lung Neuroendocrine Tumor Diagnosis.
Boutsikou E; Porpodis K; Chatzipavlidou V; Hardavella G; Gerasimou G; Domvri K; Papadopoulos N; Avramidou V; Spyratos D; Kontakiotis T; Zarogoulidis K
Technol Cancer Res Treat; 2019 Jan; 18():1533033819842586. PubMed ID: 31079574
[TBL] [Abstract][Full Text] [Related]
50. Survival After Distant Metastasis in Head and Neck Cancer.
Wiegand S; Zimmermann A; Wilhelm T; Werner JA
Anticancer Res; 2015 Oct; 35(10):5499-502. PubMed ID: 26408715
[TBL] [Abstract][Full Text] [Related]
51. [Clinicopathological classification and prognostic factors of gastrointestinal neuroendocrine neoplasms: an analysis of 119 cases].
Ma X; Zhao W; Zhuang C; Wang X; Tu L; Wang M; Sun Y; Cao H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):997-1001. PubMed ID: 28900989
[TBL] [Abstract][Full Text] [Related]
52. Metastatic bone disease and tumour-induced hypercalcaemia: treatment options.
Heatley S
Int J Palliat Nurs; 2004 Jan; 10(1):41-6. PubMed ID: 14966444
[TBL] [Abstract][Full Text] [Related]
53. Unique Metastatic Patterns in Neuroendocrine Neoplasms of Different Primary Origin.
Hermans BCM; de Vos-Geelen J; Derks JL; Latten L; Liem IH; van der Zwan JM; Speel EM; Dercksen MW; Dingemans AC
Neuroendocrinology; 2021; 111(11):1111-1120. PubMed ID: 33227805
[TBL] [Abstract][Full Text] [Related]
54. Identifying Prognostic Factors for Well-Differentiated Metastatic Pancreatic Neuroendocrine Tumours: A Retrospective International Multicentre Cohort Study.
Jiménez-Fonseca P; Krug S; Tamagno G; Fierro Maya F; Monléon Getino A; Rodriguez Casado CI; Costa F; de Herder WW; Jann H
Neuroendocrinology; 2018; 107(4):315-323. PubMed ID: 30025389
[TBL] [Abstract][Full Text] [Related]
55. Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
Santoni M; Conti A; Procopio G; Porta C; Ibrahim T; Barni S; Guida FM; Fontana A; Berruti A; Berardi R; Massari F; Vincenzi B; Ortega C; Ottaviani D; Carteni G; Lanzetta G; De Lisi D; Silvestris N; Satolli MA; Collovà E; Russo A; Badalamenti G; Luzi Fedeli S; Tanca FM; Adamo V; Maiello E; Sabbatini R; Felici A; Cinieri S; Montironi R; Bracarda S; Tonini G; Cascinu S; Santini D
J Exp Clin Cancer Res; 2015 Feb; 34(1):10. PubMed ID: 25651794
[TBL] [Abstract][Full Text] [Related]
56. Classification and Prognostic Stratification of Bronchopulmonary Neuroendocrine Neoplasms.
Oka N; Kasajima A; Konukiewitz B; Sakurada A; Okada Y; Kameya T; Weichert W; Ishikawa Y; Suzuki H; Sasano H; Klöppel G
Neuroendocrinology; 2020; 110(5):393-403. PubMed ID: 31422400
[TBL] [Abstract][Full Text] [Related]
57. Current concepts in the diagnosis and management of neuroendocrine neoplasms of unknown primary origin.
Alexandraki KI; Tsoli M; Kyriakopoulos G; Angelousi A; Nikolopoulos G; Kolomodi D; Kaltsas GA
Minerva Endocrinol; 2019 Dec; 44(4):378-386. PubMed ID: 30991795
[TBL] [Abstract][Full Text] [Related]
58. Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.
Reinert CP; Sekler J; la Fougère C; Pfannenberg C; Gatidis S
Eur Radiol; 2020 Mar; 30(3):1325-1333. PubMed ID: 31728688
[TBL] [Abstract][Full Text] [Related]
59. Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in Latvia.
Ptasnuka M; Ozolins A; Narbuts Z; Truskovs A; Sperga M; Plaudis H
World J Surg; 2020 Feb; 44(2):585-593. PubMed ID: 31605174
[TBL] [Abstract][Full Text] [Related]
60. Grading of neuroendocrine neoplasms: mitoses and Ki-67 are both essential.
van Velthuysen ML; Groen EJ; van der Noort V; van de Pol A; Tesselaar ME; Korse CM
Neuroendocrinology; 2014; 100(2-3):221-7. PubMed ID: 25358267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]